first
report
wuhan
peopl
republ
china
decemb
avail
patholog
data
sarscov
infect
mainli
obtain
autopsi
predomin
viscer
macroscop
chang
fatal
sarscov
case
edemat
lung
increas
gross
weight
multipl
area
congest
enlarg
lymph
node
pulmonari
hila
abdomin
caviti
well
diminish
spleen
size
reduc
spleen
weight
morpholog
chang
bronchial
epitheli
denud
loss
cilia
squamou
metaplasia
histolog
featur
earli
phase
pulmonari
sarscov
infect
commonli
associ
acut
diffus
alveolar
damag
later
phase
diseas
demonstr
combin
diffus
alveolar
damag
acut
fibrin
organ
pneumonia
larg
number
sarscov
particl
genom
sequenc
detect
within
circul
lymphocyt
monocyt
lymphoid
tissu
well
epitheli
cell
respiratori
tract
intestin
mucosa
epithelium
renal
distal
tubul
neuron
brain
tissueresid
macrophag
resid
differ
organ
coloc
sarscov
rna
cellular
cytokeratin
within
lung
evid
immunofluoresc
situ
hybrid
suggest
pneumocyt
becom
infect
accordingli
electron
microscop
examin
also
show
sarscov
virion
nucleocapsid
inclus
pneumocyt
addit
sarscov
may
occasion
identifi
alveolar
macrophag
lung
mechan
underli
sever
pathogen
sarscov
far
fulli
understood
extens
lung
damag
sarscovinfect
patient
appear
associ
high
initi
viru
titer
increas
monocyt
macrophag
neutrophil
infiltr
lung
elev
level
serum
proinflammatori
cytokin
chemokin
high
serum
level
proinflammatori
cytokin
interferon
transform
growth
chemokin
found
patient
sar
sever
diseas
compar
individu
uncompl
sar
addit
earli
induct
well
subsequ
hyperproduct
coincid
lack
product
thought
contribut
immunopatholog
process
involv
lung
injuri
sarscov
infect
addit
robust
persist
express
ifnstimul
gene
isg
accompani
earli
sar
sequela
also
shown
sarscov
infect
result
delay
express
type
ifn
delayedtyp
ifn
signal
accompani
robust
viru
replic
found
promot
accumul
pathogen
inflammatori
monocyt
macrophag
result
elev
lung
cytokinechemokin
level
vascular
leakag
impair
virusspecif
cell
respons
understand
pathophysiolog
chang
caus
merscov
infect
reli
limit
number
autopsi
biopsi
case
studi
indic
patholog
featur
merscov
infect
includ
exud
diffus
alveolar
damag
hyalin
membran
pulmonari
edema
type
ii
pneumocyt
hyperplasia
interstiti
pneumonia
predominantli
lymphocyt
multinucl
syncyti
cell
bronchial
submucos
gland
necrosi
also
observ
bronchial
lesion
compris
patholog
basi
respiratori
failur
radiolog
abnorm
merscov
infect
target
cell
merscov
infect
lung
includ
pneumocyt
multinucl
epitheli
cell
bronchial
submucos
gland
cell
cell
express
multifunct
cell
surfac
protein
call
dipeptidyl
peptidas
also
known
constitut
primari
entri
receptor
merscov
ultrastructur
viral
particl
found
pneumocyt
pulmonari
macrophag
macrophag
infiltr
skelet
muscl
renal
proxim
tubular
epitheli
cell
consist
ultrastructur
find
kidney
renal
biopsi
demonstr
acut
tubulointerstiti
nephriti
acut
tubular
sclerosi
proteinac
cast
format
entri
receptor
merscov
wide
express
epitheli
cell
kidney
alveoli
small
intestin
liver
prostat
activ
leukocyt
suggest
rang
merscov
tissu
tropism
broader
coronaviru
accordingli
merscov
found
abl
infect
mani
human
immun
cell
includ
dendrit
cell
genet
sequenc
analysi
reveal
belong
genu
nucleotid
ident
sarscov
ident
merscov
furthermor
report
ident
across
entir
genom
bat
coronaviru
inocul
onto
surfac
layer
human
airway
epitheli
cell
vitro
caus
cytopath
effect
cessat
cilium
beat
cell
infect
cluster
onset
like
affect
older
male
comorbid
result
sever
even
fatal
respiratori
diseas
major
clinic
symptom
result
infect
prodrom
phase
includ
fever
dri
cough
myalgia
fatigu
diarrhea
mani
patient
also
develop
dyspnea
lymphopenia
complic
infect
includ
acut
respiratori
distress
syndrom
rnaaemia
acut
cardiac
injuri
secondari
super
infect
report
case
includ
asymptomat
patient
abnorm
find
concern
chest
comput
tomographi
ct
indic
bilater
groundglass
opac
prototyp
find
chest
ct
imag
serious
ill
patient
requir
intens
care
unit
icu
admiss
bilater
multipl
lobular
subsegment
area
consolid
nonicu
patient
result
suggest
immunopatholog
may
also
play
relev
role
develop
diseas
sever
comprehens
lesson
learn
sarscov
merscov
outbreak
provid
despit
inher
tragedi
valuabl
experi
insight
fight
epidem
drug
inhibit
viral
dissemin
disrupt
viral
replic
may
reduc
coronavirusinduc
direct
cytopath
effect
treatment
restrain
host
inflammatori
respons
eg
antibodi
compound
neutral
cytokin
cognat
receptor
ideal
respiratori
tract
may
reduc
virustrigg
immunepatholog
infer
combin
treatment
would
suitabl
therapeut
strategi
sever
human
coronaviru
infect
howev
must
bear
mind
current
specif
antivir
treatment
avail
sar
mer
therefor
research
pathogenesi
human
coronaviru
infect
imper
identifi
appropri
therapeut
target
thank
doctor
nurs
diseas
control
worker
